| Literature DB >> 18460199 |
Jean Paul Fournier1, Anne Demeester, Bernard Charlin.
Abstract
BACKGROUND: SCT is used to assess clinical reasoning in ambiguous or uncertain situations. It allows testing on real-life situations that are not adequately measured with current tests. It probes the multiple judgments that are made in the clinical reasoning process. Scoring reflects the degree of concordance of these judgments to those of a panel of reference experts.Entities:
Mesh:
Year: 2008 PMID: 18460199 PMCID: PMC2427021 DOI: 10.1186/1472-6947-8-18
Source DB: PubMed Journal: BMC Med Inform Decis Mak ISSN: 1472-6947 Impact factor: 2.796
Figure 1Example of case from the investigation section of an SCT.
Descriptors suggested for 5-anchor scales aimed at measuring diagnosis, investigation and treatment tasks.
| If you were thinking of the following diagnosis... | ...and the following new information were to become available... | ...this hypothesis would become... |
| Diagnosis option | New information | -2 -1 0 +1 +2 |
| -2: very unlikely | 0: neither likely nor unlikely | +1: more likely |
| If you were considering the usefulness of the following investigation... | ...and the following new information were to become available... | ...you would then consider the investigation... |
| Investigative option | New information | -2 -1 0 +1 +2 |
| -2: useless | 0: neither more nor less useful | +1: useful |
| If you were considering the risk-benefit ratio of the following investigation... | ...and the following new information were to become available... | ...this new information would make the investigation... |
| Investigative option | New information | -2 -1 0 +1 +2 |
| -2: strongly contraindicated | 0: neither more or less indicated | +1: indicated |
| If you were considering the utility of the following treatment... | ...and the following new information were to become available... | ...you would then consider this treatment... |
| Treatment option | New information | -2 -1 0 +1 +2 |
| -2: useless | 0: neither more or less useful | +1: useful |
| If you were considering the risk-benefit ratio of the following treatment... | ...and the following new information were to become available... | ...you would then consider the treatment... |
| Treatment option | New information | -2 -1 0 +1 +2 |
| -2: strongly contraindicated | 0: neither more or less indicated | +1: indicated |
Script Concordance Test item quality grid, adapted from Caire
| Scenario | • Describes a challenging situation, even for experts | yes | no |
| • Describes an appropriate situation for examinees tested | yes | no | |
| • The scenario is necessary in order to understand the question and to set the context | yes | no | |
| • The clinical presentation is typical | yes | no | |
| • The scenario is correctly written | yes | no | |
| Questions | • Questions are developed following a key-feature approach | yes | no |
| • In the experts' opinion, the options are relevant | yes | no | |
| • The same option is not found in two consecutive questions | yes | no | |
| • The new information (2nd column) makes it possible to test the link between the new information and the option (1st column) in the described context | yes | no | |
| • Likert scale anchors are clearly defined and unambiguous | yes | no | |
| • Questions are developed to spread the answers equally over all the values of the Likert scale | yes | no | |
| • Questions are developed to provide balance between low and high variability | yes | no | |
| Experts' panel | • Number between 10 and 20 | yes | no |
| • The experts' panel includes experienced physicians whose presence in a jury is appropriate to the level of the examinees assessed | yes | no | |
| • Experts take the test individually, in exactly the same conditions as the examinees | yes | no | |
Figure 2Example of test item administered on line.